Email Alert | RSS    帮助

中国防痨杂志 ›› 2022, Vol. 44 ›› Issue (10): 1050-1056.doi: 10.19982/j.issn.1000-6621.20220080

• 论著 • 上一篇    下一篇

吉林省结核病患者全面推广电子药盒后的使用率及影响因素分析

杨帆1,2, 马建军1, 高迎1, 高智慧1, 袁燕莉1()   

  1. 1吉林省结核病防治科学研究院,长春 130103
    2吉林大学公共卫生学院,长春 130021
  • 收稿日期:2022-03-14 出版日期:2022-10-10 发布日期:2022-09-30
  • 通信作者: 袁燕莉 E-mail:yuanyanli7500@163.com
  • 基金资助:
    中国国家卫生和计划生育委员会-比尔及梅琳达·盖茨基金会结核病防治合作项目三期(OPP1137180)

Analysis on the adoption rate and influencing factors of electronic medication monitors in tuberculosis patients in Jilin Province

Yang Fan1,2, Ma Jianjun1, Gao Ying1, Gao Zhihui1, Yuan Yanli1()   

  1. 1Jilin Provincial Institute of Tuberculosis Prevention and Treatment, Changchun 130103, China
    2Department of Public Health in Jilin University, Changchun 130021, China
  • Received:2022-03-14 Online:2022-10-10 Published:2022-09-30
  • Contact: Yuan Yanli E-mail:yuanyanli7500@163.com
  • Supported by:
    National Health and Family Planning Commission of China-Bill and Melinda Gates Foundation TB Collaboration Project Phase Ⅲ(OPP1137180)

摘要:

目的:根据电子药盒在吉林省全面推广后的接受程度,分析影响电子药盒使用率的相关因素。 方法:搜集2019年1—12月吉林省电子药盒推广地区登记的结核病患者的资料,包括不同时间、不同地区、不同特征的人群使用电子药盒的病案数据,采用单因素和多因素logistic回归模型对结核病患者使用电子药盒的现状及其影响因素进行分析。 结果:2019年吉林省电子药盒推广地区共登记结核病患者8435例,纳入电子药盒管理的患者5231例,电子药盒使用率为62.02%。多因素logistic回归分析结果显示,20~39岁(OR=1.264,95%CI:1.026~1.558)、40~59岁(OR=1.280,95%CI:1.045~1.567)、少数民族(OR=2.176,95%CI:1.691~2.801)、职业为农牧民(OR=1.189,95%CI:1.081~1.308)、本地户籍(OR=3.425,95%CI:2.968~3.952)、患者来源为转诊追踪(OR=1.747,95%CI:1.588~1.921)、诊断结果为病原学阳性(OR=3.437,95%CI:2.779~4.250)和病原学阴性(OR=3.454,95%CI:2.790~4.278)、治疗分类为初治(OR=3.024,95%CI:2.511~3.642)的患者电子药盒使用率较高。 结论:电子药盒作为患者督导服药的工具,可以在吉林省内推广使用,特别适宜在20~59岁、农牧民、本地户籍、转诊追踪、病原学阳性/阴性和初治患者中推广。

关键词: 结核,肺, 电子药盒, 革新推广, 卫生服务管理, 因素分析,统计学

Abstract:

Objective:According to the acceptance of electronic medication monitors (EMM) after its comprehensive promotion in Jilin Province, analyze the relevant factors affecting the adoption rate of EMM. Methods:Collect the medical record data about adoption of EMM among tuberculosis patients registered in Jilin Province in 2019 at different times, in different regions and with different characteristics. Univariable and multivariable logistic regression models were used to analyze the current status and influencing factors of EMM usage in tuberculosis patients. Results:In 2019, 8435 tuberculosis patients were registered in the EMM promotion regions, and 5231 patients accepted EMM management, the adoption rate of EMM was 62.02%. Multivariable logistic regression analysis showed that patients being 20-39 years old (OR=1.264, 95%CI: 1.026-1.558) or 40-59 years old (OR=1.280, 95%CI: 1.045-1.567), non-Han ethnic groups (OR=2.176, 95%CI: 1.691-2.801), with an occupation farmer or herdsman (OR=1.189, 95%CI: 1.081-1.308), local patients (OR=3.425, 95%CI: 2.968-3.952), patient coming from referral or tracking (OR=1.747, 95%CI: 1.588-1.921), etiologically positive (OR=3.437,95%CI:2.779-4.250) or negative (OR=3.454,95%CI:2.790-4.278) patients, newly treated patients(OR=3.024, 95%CI: 2.511-3.642) got a higher rate of using EMM. Conclusion:As a tool for supervision of medication for patients, EMM can be popularized and used in Jilin Province, especially for patients aged 20-59, farmers and herdsmen, local registered residence patients, patients coming from referral and tracking, etiologically positive and negative patients and newly treated patients.

Key words: Tuberculosis,pulmonary, Electronic medication monitors, Diffusion of innovation, Health services administration, Factor analysis,statistical

中图分类号: